Market Research Industry Reports

ICON Plc (ICLR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The companys service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, functional services provision, medical imaging, laboratory services, resourcing solutions and strategic support and tactical solutions for traditional, in vitro diagnostic, and software devices. The company offers research services in areas such as cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, nonalcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, womens health therapeutics and other therapeutic areas. ICON is headquartered in Dublin, Ireland.

ICON Plc (ICLR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ICON Plc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To US$56 Million 12
Venture Financing 14
Aptiv Solutions Raises US$5.7 Million In Venture Financing 14
Merger 15
Inclinix Merges With PMG Research 15
Licensing Agreements 16
Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 16
Debt Offering 17
ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 17
Acquisition 18
ICON Acquires Mapi 18
Icon Acquires Clinical Research Management 19
Icon Acquires PMG Research from Frontier Capital 20
ICON Acquires MediMedia Pharma Solutions for USD120 Million 21
Icon Completes Acquisition Of Aptiv Solutions For US$143.5 Million 22
Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 24
ICON Plc - Key Competitors 25
ICON Plc - Key Employees 26
ICON Plc - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 30
Strategy And Business Planning 30
Mar 14, 2018: ICON opens a new office in Boston 30
Financial Announcements 31
Feb 15, 2018: ICON Reports Fourth Quarter and Full Year 2017 Results 31
Jan 09, 2018: ICON Issues Financial Guidance for Full Year 2018 33
Oct 26, 2017: ICON Reports Third Quarter 2017 Results 34
Jul 27, 2017: ICON Reports Second Quarter 2017 Results 35
Apr 27, 2017: ICON Reports First Quarter 2017 Results 36
Feb 16, 2017: ICON Reports Fourth Quarter and Full Year 2016 Results 37
Jan 09, 2017: ICON Issues Financial Guidance for Full Year 2017 38
Corporate Communications 39
Jan 09, 2018: ICON Appoints Dr. James Cummings as President of ClinicalRM 39
Nov 17, 2017: ICON Announces Appointment of Ms. Joan Garahy to Board of Directors 40
Oct 04, 2017: ICON Announces Appointment of Mr. Eugene McCague to Board of Directors 41
Product News 42
Nov 21, 2017: ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening 42
Nov 07, 2017: ICON contributes to major European research study that aims to improve treatment for traumatic brain injury 43
Feb 20, 2017: ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials 44
Other Significant Developments 45
Apr 03, 2018: ICON announces launch of Government and Public Health Solutions to support global public health 45
Nov 06, 2017: ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress 46
Oct 27, 2017: ICON and ICHOM unveil the worlds first global patient outcomes benchmarking platform 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List Of Tables

List of Tables
ICON Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To US$56 Million 12
Aptiv Solutions Raises US$5.7 Million In Venture Financing 14
Inclinix Merges With PMG Research 15
Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 16
ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 17
ICON Acquires Mapi 18
Icon Acquires Clinical Research Management 19
Icon Acquires PMG Research from Frontier Capital 20
ICON Acquires MediMedia Pharma Solutions for USD120 Million 21
Icon Completes Acquisition Of Aptiv Solutions For US$143.5 Million 22
Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 24
ICON Plc, Key Competitors 25
ICON Plc, Key Employees 26
ICON Plc, Subsidiaries 27

List Of Figures

List of Figures
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10

USD 4795View Report

USD 4795View Report

ICON Plc (ICLR) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services

USD 250View Report

ICON plc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

ICON plc Company Profile is a detailed strategic and analytical report on ICON plc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :48
Country :Ireland
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube